Lumacaftor Yields Reversal of Impaired Cerebral Blood Flow in Heart Failure Patients

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Lumacaftor Yields Reversal of Impaired Cerebral Blood Flow in Heart Failure Patients	Cognition Disorders, Cognitive Dysfunction, cognitive disorder, psychiatric disorder	Recruiting	Phase 2	2026-07-17		NCT07695090

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Qanatpharma AG	1
Qanatpharma Canada LTD	1

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
St. Michael's Hospital	Toronto	Canada	3
University Health Network (UHN) Peter Munk Cardiac Centre	Toronto	Canada	1

Clinical trials